True North Advisors’s Eli Lilly LLY Stock Holding History

True North Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.73M	Sell	3,109 -151	-5%	-$154K	0.36%	56
2026 Q1	$3M	Sell	3,260 -104	-3%	-$105K	0.34%	53
2025 Q4	$3.62M	Sell	3,364 -96	-3%	-$91.8K	0.47%	39
2025 Q3	$2.64M	Buy	3,460 +504	+17%	+$375K	0.42%	39
2025 Q2	$2.3M	Sell	2,956 -399	-12%	-$310K	0.44%	52
2025 Q1	$2.77M	Sell	3,355 -128	-4%	-$107K	0.49%	48
2024 Q4	$2.69M	Buy	3,483 +258	+8%	+$214K	0.63%	36
2024 Q3	$2.86M	Sell	3,225 -42	-1%	-$37.8K	0.75%	23
2024 Q2	$2.96M	Sell	3,267 -1,042	-24%	-$834K	0.79%	23
2024 Q1	$3.35M	Buy	4,309 +18	+0.4%	+$12.8K	0.93%	17
2023 Q4	$2.5M	Sell	4,291 -114	-3%	-$66.5K	0.64%	24
2023 Q3	$2.37M	Sell	4,405 -1,081	-20%	-$557K	0.73%	21
2023 Q2	$2.57M	Buy	5,486 +316	+6%	+$133K	0.73%	26
2023 Q1	$1.78M	Buy	5,170 +670	+15%	+$226K	0.52%	46
2022 Q4	$1.65M	Hold	4,500	–	–	0.56%	43
2022 Q3	$1.46M	Sell	4,500 -138	-3%	-$43.7K	0.48%	51
2022 Q2	$1.5M	Buy	4,638 +174	+4%	+$52.2K	0.47%	52
2022 Q1	$1.28M	Buy	4,464 +758	+20%	+$195K	0.34%	69
2021 Q4	$1.02M	Buy	3,706 +68	+2%	+$17.2K	0.17%	111
2021 Q3	$840K	Buy	3,638 +42	+1%	+$10.4K	0.17%	115
2021 Q2	$825K	Sell	3,596 -41	-1%	-$8.24K	0.17%	109
2021 Q1	$679K	Buy	3,637 +182	+5%	+$35.6K	0.16%	108
2020 Q4	$583K	Sell	3,455 -193	-5%	-$28.8K	0.15%	108
2020 Q3	$539K	Buy	3,648 +346	+10%	+$53.5K	0.16%	102
2020 Q2	$542K	Buy	+3,302	New	+$507K	0.13%	112

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

True North Advisors's LLY Position: Q2 2026 in Review

True North Advisors reduced its Eli Lilly (LLY) stake by 4.6% in Q2 2026, selling an estimated $154K and leaving 3,109 shares worth $3.73M. The position accounts for 0.36% of the portfolio, ranked #56.

True North Advisors first reported a position in LLY in Q2 2020 and has held it in 25 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

True North Advisors held 3,109 shares of Eli Lilly worth $3.73M as of Q2 2026.
True North Advisors sold 151 Eli Lilly shares in Q2 2026, an estimated $154K.
Eli Lilly made up 0.36% of True North Advisors's portfolio in Q2 2026, its #56 holding.
True North Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 25 quarters since.
1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.